June 12, 2025 - 22:17
Micron Technology has announced a significant investment aimed at enhancing semiconductor manufacturing in upstate New York. The plan includes the construction of up to two additional fabrication facilities, which are expected to bolster local job creation and strengthen the region's position in the tech industry. This move comes as part of a broader strategy to increase domestic semiconductor production amid rising global demand.
The investment has garnered support from the federal government, emphasizing the importance of local manufacturing capabilities in the face of supply chain challenges. Officials highlighted that this initiative not only promotes economic growth but also ensures national security by reducing reliance on foreign semiconductor sources.
With this expansion, Micron aims to leverage the skilled workforce in New York while contributing to technological advancements in the semiconductor sector. The project is anticipated to have a lasting impact on the local economy, creating numerous jobs and fostering innovation in the region.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...